Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy adults assessing serotonin transporter occupancy using the PET tracer 11C-DASB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 11C-DASB

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED